Hoshimoto Sojun, Ueda Masakazu, Jinno Hiromitsu, Kitajima Masaki, Futami Junichiro, Seno Masaharu
Department of Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Anticancer Res. 2006 Mar-Apr;26(2A):857-63.
We previously showed the usefulness of a fused protein of human pancreatic ribonuclease1 (hRNase1) with human epidermal growth factor (hEGF) for molecular targeting of EGF receptor (EGFR)-overexpressing cells. In this study, the mechanisms underlying the inhibition of cell growth by RNase-EGF fused proteins was confirmed.
Des.1-7 hRNase1 was genetically fused to hEGF. The fused proteins were expressed and isolated from Escherichia coli. The internalization of hRNase1-hEGF was confirmed by confocal fluorescence microscopy. The growth-inhibitory effect of the fused proteins was evaluated by MTT assay.
FITC-labelled hRNase1-hEGF was internalized into EGFR-overexpressing A431 cells. The internalization was not observed in A431 cells pre-treated with hEGF and EGFR-deficient H69 cells. The growth-inhibitory effect of des.1-7 hRNase1-hEGF against A431 cells was statistically significantly more pronounced than that of hRNase1-hEGF.
RNase-EGF fused proteins are internalized through EGFR and inhibit cell growth by exerting their ribonucleolytic activity in the cytosol.
我们之前已证明人胰腺核糖核酸酶1(hRNase1)与人表皮生长因子(hEGF)的融合蛋白对表皮生长因子受体(EGFR)过表达细胞具有分子靶向作用。在本研究中,对核糖核酸酶 - EGF融合蛋白抑制细胞生长的潜在机制进行了确认。
将Des.1 - 7 hRNase1与hEGF进行基因融合。融合蛋白在大肠杆菌中表达并分离。通过共聚焦荧光显微镜确认hRNase1 - hEGF的内化。通过MTT法评估融合蛋白的生长抑制作用。
异硫氰酸荧光素(FITC)标记的hRNase1 - hEGF被内化到EGFR过表达的A431细胞中。在用hEGF预处理的A431细胞和EGFR缺陷的H69细胞中未观察到内化现象。Des.1 - 7 hRNase1 - hEGF对A431细胞的生长抑制作用在统计学上比hRNase1 - hEGF更显著。
核糖核酸酶 - EGF融合蛋白通过EGFR内化,并通过在细胞质中发挥其核糖核酸酶活性来抑制细胞生长。